| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 2.04e-06 | 59 | 31 | 4 | GO:0031593 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.78e-04 | 206 | 31 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 5.78e-04 | 23 | 31 | 2 | GO:0046965 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 3.79e-05 | 127 | 31 | 4 | GO:0061640 | |
| GeneOntologyBiologicalProcess | mitotic spindle midzone assembly | 1.19e-04 | 11 | 31 | 2 | GO:0051256 | |
| GeneOntologyBiologicalProcess | mitotic spindle elongation | 1.43e-04 | 12 | 31 | 2 | GO:0000022 | |
| GeneOntologyBiologicalProcess | spindle midzone assembly | 1.97e-04 | 14 | 31 | 2 | GO:0051255 | |
| GeneOntologyBiologicalProcess | spindle elongation | 1.97e-04 | 14 | 31 | 2 | GO:0051231 | |
| GeneOntologyBiologicalProcess | cytokinesis | 2.37e-04 | 204 | 31 | 4 | GO:0000910 | |
| GeneOntologyCellularComponent | septin complex | 1.92e-04 | 14 | 31 | 2 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 1.92e-04 | 14 | 31 | 2 | GO:0005940 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 2.52e-04 | 16 | 31 | 2 | GO:0032156 | |
| GeneOntologyCellularComponent | midbody | 3.11e-04 | 222 | 31 | 4 | GO:0030496 | |
| GeneOntologyCellularComponent | autophagosome | 7.20e-04 | 119 | 31 | 3 | GO:0005776 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 1.45e-03 | 38 | 31 | 2 | GO:0030125 | |
| GeneOntologyCellularComponent | aggresome | 1.60e-03 | 40 | 31 | 2 | GO:0016235 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.70e-03 | 596 | 31 | 5 | GO:0005667 | |
| MousePheno | increased dendritic spine number | 1.08e-05 | 3 | 27 | 2 | MP:0021019 | |
| MousePheno | decreased brain size | 1.71e-05 | 295 | 27 | 6 | MP:0000774 | |
| MousePheno | dilated third ventricle | 3.69e-05 | 34 | 27 | 3 | MP:0000827 | |
| MousePheno | abnormal brain size | 6.57e-05 | 375 | 27 | 6 | MP:0000771 | |
| MousePheno | small hippocampus | 9.23e-05 | 46 | 27 | 3 | MP:0008283 | |
| MousePheno | behavioral developmental delay | 9.99e-05 | 8 | 27 | 2 | MP:0021165 | |
| MousePheno | abnormal hippocampus size | 1.58e-04 | 55 | 27 | 3 | MP:0008281 | |
| MousePheno | abnormal dendritic spine number | 1.60e-04 | 10 | 27 | 2 | MP:0021017 | |
| Domain | Ubiquilin | 8.25e-08 | 6 | 31 | 3 | IPR015496 | |
| Domain | STI1_HS-bd | 4.93e-07 | 10 | 31 | 3 | IPR006636 | |
| Domain | STI1 | 4.93e-07 | 10 | 31 | 3 | SM00727 | |
| Domain | Ubiquilin-1/2 | 2.67e-06 | 2 | 31 | 2 | IPR028430 | |
| Domain | UBA-like | 3.68e-06 | 64 | 31 | 4 | IPR009060 | |
| Domain | 6-PGluconate_DH_C-like | 3.94e-06 | 19 | 31 | 3 | IPR008927 | |
| Domain | UBA | 1.63e-05 | 30 | 31 | 3 | SM00165 | |
| Domain | UBA | 2.85e-05 | 36 | 31 | 3 | PF00627 | |
| Domain | UBIQUITIN_1 | 3.10e-05 | 37 | 31 | 3 | PS00299 | |
| Domain | UBQ | 4.88e-05 | 43 | 31 | 3 | SM00213 | |
| Domain | UBA | 5.24e-05 | 44 | 31 | 3 | IPR015940 | |
| Domain | UBA | 6.39e-05 | 47 | 31 | 3 | PS50030 | |
| Domain | ubiquitin | 6.39e-05 | 47 | 31 | 3 | PF00240 | |
| Domain | UBIQUITIN_2 | 9.70e-05 | 54 | 31 | 3 | PS50053 | |
| Domain | Ubiquitin_dom | 1.20e-04 | 58 | 31 | 3 | IPR000626 | |
| Domain | Septin | 2.06e-04 | 13 | 31 | 2 | PF00735 | |
| Domain | G_SEPTIN_dom | 2.06e-04 | 13 | 31 | 2 | IPR030379 | |
| Domain | G_SEPTIN | 2.06e-04 | 13 | 31 | 2 | PS51719 | |
| Domain | Prefoldin | 2.29e-04 | 72 | 31 | 3 | IPR009053 | |
| Domain | Septin | 2.40e-04 | 14 | 31 | 2 | IPR016491 | |
| Domain | P-loop_NTPase | 3.92e-04 | 848 | 31 | 7 | IPR027417 | |
| Domain | ZnF_U1 | 1.05e-03 | 29 | 31 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.05e-03 | 29 | 31 | 2 | IPR003604 | |
| Domain | SNF2_N | 1.28e-03 | 32 | 31 | 2 | PF00176 | |
| Domain | SNF2_N | 1.28e-03 | 32 | 31 | 2 | IPR000330 | |
| Domain | Kinesin_motor_CS | 2.10e-03 | 41 | 31 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 2.31e-03 | 43 | 31 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 2.42e-03 | 44 | 31 | 2 | PS00411 | |
| Domain | - | 2.42e-03 | 44 | 31 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 2.42e-03 | 44 | 31 | 2 | IPR001752 | |
| Domain | Kinesin | 2.42e-03 | 44 | 31 | 2 | PF00225 | |
| Domain | KISc | 2.42e-03 | 44 | 31 | 2 | SM00129 | |
| Domain | KINESIN_MOTOR_2 | 2.42e-03 | 44 | 31 | 2 | PS50067 | |
| Domain | Ubiquitin-rel_dom | 3.45e-03 | 184 | 31 | 3 | IPR029071 | |
| Domain | RHOGAP | 5.04e-03 | 64 | 31 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 5.04e-03 | 64 | 31 | 2 | IPR000198 | |
| Domain | - | 5.04e-03 | 64 | 31 | 2 | 1.10.555.10 | |
| Domain | - | 7.19e-03 | 746 | 31 | 5 | 3.40.50.300 | |
| Domain | Rho_GTPase_activation_prot | 9.34e-03 | 88 | 31 | 2 | IPR008936 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 4.18e-04 | 18 | 24 | 2 | M26942 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 5.25e-04 | 630 | 24 | 6 | M11480 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 5.95e-04 | 645 | 24 | 6 | MM15232 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 6.67e-04 | 102 | 24 | 3 | MM15498 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 7.25e-04 | 105 | 24 | 3 | M27752 | |
| Pubmed | Herp enhances ER-associated protein degradation by recruiting ubiquilins. | 2.56e-09 | 4 | 31 | 3 | 18307982 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.15e-09 | 430 | 31 | 8 | 35044719 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.88e-09 | 283 | 31 | 7 | 30585729 | |
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 35247097 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.15e-08 | 351 | 31 | 7 | 38297188 | |
| Pubmed | The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-coupled receptor endocytosis. | 2.24e-08 | 7 | 31 | 3 | 18199683 | |
| Pubmed | 2.24e-08 | 7 | 31 | 3 | 30664872 | ||
| Pubmed | Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. | 3.58e-08 | 8 | 31 | 3 | 23459205 | |
| Pubmed | Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne. | 1.16e-07 | 50 | 31 | 4 | 31699778 | |
| Pubmed | 1.24e-07 | 268 | 31 | 6 | 33640491 | ||
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 1.82e-07 | 13 | 31 | 3 | 27477512 | |
| Pubmed | 3.38e-07 | 1103 | 31 | 9 | 34189442 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 7.69e-07 | 2 | 31 | 2 | 36482480 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 7.69e-07 | 2 | 31 | 2 | 10873665 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 21565503 | ||
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 7.69e-07 | 2 | 31 | 2 | 31486502 | |
| Pubmed | Identification of septins in neurofibrillary tangles in Alzheimer's disease. | 7.69e-07 | 2 | 31 | 2 | 9811347 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 10773663 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 7929562 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 36849972 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 7.69e-07 | 2 | 31 | 2 | 30081192 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 31616463 | ||
| Pubmed | Structural basis for the ATP-induced isomerization of kinesin. | 7.69e-07 | 2 | 31 | 2 | 23500491 | |
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 7.69e-07 | 2 | 31 | 2 | 31067151 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 28350061 | ||
| Pubmed | Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. | 7.69e-07 | 2 | 31 | 2 | 9658142 | |
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 7.69e-07 | 2 | 31 | 2 | 10559369 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 29247619 | ||
| Pubmed | Kif4 interacts with EB1 and stabilizes microtubules downstream of Rho-mDia in migrating fibroblasts. | 7.69e-07 | 2 | 31 | 2 | 24658398 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 35063704 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.18e-06 | 394 | 31 | 6 | 27248496 | |
| Pubmed | 1.66e-06 | 418 | 31 | 6 | 34709266 | ||
| Pubmed | Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein. | 2.31e-06 | 3 | 31 | 2 | 10978527 | |
| Pubmed | KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. | 2.31e-06 | 3 | 31 | 2 | 16630823 | |
| Pubmed | Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. | 2.31e-06 | 3 | 31 | 2 | 20529957 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 35579738 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 16890532 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 17098253 | ||
| Pubmed | KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons. | 2.31e-06 | 3 | 31 | 2 | 19158085 | |
| Pubmed | 2.89e-06 | 1429 | 31 | 9 | 35140242 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPC1 EPS15 SMARCAD1 PFDN5 CLINT1 UBQLN2 UBQLN1 LUC7L2 SEPTIN2 | 3.35e-06 | 1455 | 31 | 9 | 22863883 |
| Pubmed | Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility. | 3.44e-06 | 33 | 31 | 3 | 17558393 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 15915442 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 18684836 | ||
| Pubmed | Characterization of a gamma-adaptin ear-binding motif in enthoprotin. | 4.61e-06 | 4 | 31 | 2 | 14675752 | |
| Pubmed | PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. | 4.61e-06 | 4 | 31 | 2 | 19148225 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 28125646 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 23300874 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 36423739 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 36827983 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 16813565 | ||
| Pubmed | 5.00e-06 | 284 | 31 | 5 | 29459677 | ||
| Pubmed | Nuclear export of ubiquitinated proteins via the UBIN-POST system. | 5.30e-06 | 38 | 31 | 3 | 29666234 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 15975090 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 21082023 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 10549293 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 17082820 | ||
| Pubmed | Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. | 7.68e-06 | 5 | 31 | 2 | 11827521 | |
| Pubmed | Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction. | 7.68e-06 | 5 | 31 | 2 | 16159959 | |
| Pubmed | 1.20e-05 | 591 | 31 | 6 | 15231748 | ||
| Pubmed | The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. | 1.61e-05 | 7 | 31 | 2 | 10983987 | |
| Pubmed | Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. | 1.61e-05 | 7 | 31 | 2 | 23774650 | |
| Pubmed | Ubiquilins Chaperone and Triage Mitochondrial Membrane Proteins for Degradation. | 1.61e-05 | 7 | 31 | 2 | 27345149 | |
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 23362347 | ||
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 20059542 | ||
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 17962186 | ||
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 1447303 | ||
| Pubmed | Genetic mapping in the mouse of Kif4, a gene encoding a kinesin-like motor protein. | 1.61e-05 | 7 | 31 | 2 | 9196009 | |
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 18535780 | ||
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 16862145 | ||
| Pubmed | NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes. | 2.15e-05 | 8 | 31 | 2 | 21292004 | |
| Pubmed | EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking. | 2.76e-05 | 9 | 31 | 2 | 12538641 | |
| Pubmed | Clint: a novel clathrin-binding ENTH-domain protein at the Golgi. | 2.76e-05 | 9 | 31 | 2 | 12429846 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 2.82e-05 | 66 | 31 | 3 | 24811749 | |
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 29101321 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 15843429 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 15758025 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 10847592 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 12446761 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 36613751 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 20493910 | ||
| Pubmed | 4.66e-05 | 78 | 31 | 3 | 28611094 | ||
| Pubmed | 4.84e-05 | 79 | 31 | 3 | 27325702 | ||
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 12189208 | ||
| Pubmed | PAQR9 Modulates BAG6-mediated protein quality control of mislocalized membrane proteins. | 5.05e-05 | 12 | 31 | 2 | 31904842 | |
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 12482968 | ||
| Pubmed | Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. | 6.95e-05 | 14 | 31 | 2 | 12039952 | |
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 10567404 | ||
| Pubmed | 8.31e-05 | 261 | 31 | 4 | 33277362 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 23870121 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 22575789 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 24368734 | ||
| Pubmed | 9.79e-05 | 529 | 31 | 5 | 14621295 | ||
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 1.17e-04 | 18 | 31 | 2 | 17500065 | |
| Pubmed | Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene. | 1.30e-04 | 19 | 31 | 2 | 22982455 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.45e-04 | 20 | 31 | 2 | 29785026 | |
| Pubmed | 1.45e-04 | 20 | 31 | 2 | 11877444 | ||
| Pubmed | 1.45e-04 | 20 | 31 | 2 | 35177643 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.53e-04 | 582 | 31 | 5 | 20467437 | |
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 19596656 | ||
| Interaction | PAX9 interactions | 4.14e-08 | 130 | 31 | 6 | int:PAX9 | |
| Interaction | EGR2 interactions | 2.11e-07 | 171 | 31 | 6 | int:EGR2 | |
| Interaction | PLAAT3 interactions | 5.39e-07 | 11 | 31 | 3 | int:PLAAT3 | |
| Interaction | ZG16 interactions | 7.18e-07 | 12 | 31 | 3 | int:ZG16 | |
| Interaction | XRCC6 interactions | SUGP1 KIF4A NCOA6 ZFHX3 SCAF11 SMARCAD1 CHD7 UBQLN2 PLGRKT SEPTIN2 | 7.49e-07 | 928 | 31 | 10 | int:XRCC6 |
| Interaction | SERPINI2 interactions | 2.65e-06 | 18 | 31 | 3 | int:SERPINI2 | |
| Interaction | SRGN interactions | 3.69e-06 | 20 | 31 | 3 | int:SRGN | |
| Interaction | RSRC2 interactions | 5.16e-06 | 75 | 31 | 4 | int:RSRC2 | |
| Interaction | SP7 interactions | 6.01e-06 | 304 | 31 | 6 | int:SP7 | |
| Interaction | SMIM2 interactions | 6.86e-06 | 3 | 31 | 2 | int:SMIM2 | |
| Interaction | DEFB115 interactions | 6.86e-06 | 3 | 31 | 2 | int:DEFB115 | |
| Interaction | SLC5A10 interactions | 6.86e-06 | 3 | 31 | 2 | int:SLC5A10 | |
| Interaction | SCG5 interactions | 8.37e-06 | 26 | 31 | 3 | int:SCG5 | |
| Interaction | PPIC interactions | 8.37e-06 | 26 | 31 | 3 | int:PPIC | |
| Interaction | NSFL1C interactions | 1.04e-05 | 192 | 31 | 5 | int:NSFL1C | |
| Interaction | KLHL42 interactions | 1.11e-05 | 91 | 31 | 4 | int:KLHL42 | |
| Interaction | MDK interactions | 1.11e-05 | 91 | 31 | 4 | int:MDK | |
| Interaction | STMN1 interactions | 1.12e-05 | 195 | 31 | 5 | int:STMN1 | |
| Interaction | OR4N2 interactions | 1.17e-05 | 29 | 31 | 3 | int:OR4N2 | |
| Interaction | ERP27 interactions | 1.30e-05 | 30 | 31 | 3 | int:ERP27 | |
| Interaction | FEV interactions | 1.36e-05 | 203 | 31 | 5 | int:FEV | |
| Interaction | CLINT1 interactions | 1.49e-05 | 207 | 31 | 5 | int:CLINT1 | |
| Interaction | NME3 interactions | 1.62e-05 | 100 | 31 | 4 | int:NME3 | |
| Interaction | CSTF2T interactions | 1.96e-05 | 105 | 31 | 4 | int:CSTF2T | |
| Interaction | EPS15 interactions | 2.00e-05 | 220 | 31 | 5 | int:EPS15 | |
| Interaction | MIEF2 interactions | 2.09e-05 | 35 | 31 | 3 | int:MIEF2 | |
| Interaction | GUCA2B interactions | 2.28e-05 | 5 | 31 | 2 | int:GUCA2B | |
| Interaction | TBR1 interactions | 2.62e-05 | 113 | 31 | 4 | int:TBR1 | |
| Interaction | ITPRIPL1 interactions | 3.13e-05 | 40 | 31 | 3 | int:ITPRIPL1 | |
| Interaction | ELK3 interactions | 3.32e-05 | 120 | 31 | 4 | int:ELK3 | |
| Interaction | OR6T1 interactions | 3.38e-05 | 41 | 31 | 3 | int:OR6T1 | |
| Interaction | C1QTNF4 interactions | 3.42e-05 | 6 | 31 | 2 | int:C1QTNF4 | |
| Interaction | NUP43 interactions | 3.67e-05 | 625 | 31 | 7 | int:NUP43 | |
| Interaction | CRX interactions | 3.97e-05 | 254 | 31 | 5 | int:CRX | |
| Interaction | SMIM19 interactions | 4.79e-05 | 7 | 31 | 2 | int:SMIM19 | |
| Interaction | HERPUD1 interactions | 5.10e-05 | 47 | 31 | 3 | int:HERPUD1 | |
| Interaction | EPS15L1 interactions | 5.74e-05 | 138 | 31 | 4 | int:EPS15L1 | |
| Interaction | GPR162 interactions | 6.38e-05 | 8 | 31 | 2 | int:GPR162 | |
| Interaction | WFDC12 interactions | 6.38e-05 | 8 | 31 | 2 | int:WFDC12 | |
| Interaction | IGFBP6 interactions | 6.53e-05 | 51 | 31 | 3 | int:IGFBP6 | |
| Interaction | KDM1A interactions | 6.62e-05 | 941 | 31 | 8 | int:KDM1A | |
| Interaction | STAM2 interactions | 7.34e-05 | 147 | 31 | 4 | int:STAM2 | |
| Interaction | CEBPA interactions | 7.43e-05 | 1245 | 31 | 9 | int:CEBPA | |
| Interaction | TLX3 interactions | 7.57e-05 | 291 | 31 | 5 | int:TLX3 | |
| Interaction | SERPINE1 interactions | 7.75e-05 | 54 | 31 | 3 | int:SERPINE1 | |
| Interaction | SLC17A2 interactions | 8.64e-05 | 56 | 31 | 3 | int:SLC17A2 | |
| Interaction | NPPA interactions | 1.01e-04 | 59 | 31 | 3 | int:NPPA | |
| Interaction | ZFAND2B interactions | 1.06e-04 | 60 | 31 | 3 | int:ZFAND2B | |
| Interaction | SEZ6L interactions | 1.25e-04 | 11 | 31 | 2 | int:SEZ6L | |
| Interaction | RTL8A interactions | 1.25e-04 | 11 | 31 | 2 | int:RTL8A | |
| Interaction | PAQR9 interactions | 1.25e-04 | 11 | 31 | 2 | int:PAQR9 | |
| Interaction | SLC45A4 interactions | 1.25e-04 | 11 | 31 | 2 | int:SLC45A4 | |
| Interaction | HERC3 interactions | 1.29e-04 | 64 | 31 | 3 | int:HERC3 | |
| Interaction | PHF5A interactions | 1.32e-04 | 171 | 31 | 4 | int:PHF5A | |
| Interaction | DESI1 interactions | 1.35e-04 | 65 | 31 | 3 | int:DESI1 | |
| Interaction | VSX1 interactions | 1.41e-04 | 66 | 31 | 3 | int:VSX1 | |
| Interaction | MYDGF interactions | 1.41e-04 | 66 | 31 | 3 | int:MYDGF | |
| Interaction | TEAD1 interactions | 1.47e-04 | 176 | 31 | 4 | int:TEAD1 | |
| Interaction | FDCSP interactions | 1.50e-04 | 12 | 31 | 2 | int:FDCSP | |
| Interaction | PSMD8 interactions | 1.67e-04 | 182 | 31 | 4 | int:PSMD8 | |
| Interaction | PPIB interactions | 1.68e-04 | 345 | 31 | 5 | int:PPIB | |
| Interaction | TERF2IP interactions | 1.69e-04 | 552 | 31 | 6 | int:TERF2IP | |
| Interaction | LHX2 interactions | 1.71e-04 | 183 | 31 | 4 | int:LHX2 | |
| Interaction | RTL8B interactions | 1.77e-04 | 13 | 31 | 2 | int:RTL8B | |
| Interaction | PLAAT2 interactions | 1.77e-04 | 13 | 31 | 2 | int:PLAAT2 | |
| Interaction | SOD3 interactions | 1.77e-04 | 13 | 31 | 2 | int:SOD3 | |
| Interaction | DAZAP2 interactions | 1.82e-04 | 186 | 31 | 4 | int:DAZAP2 | |
| Interaction | UBFD1 interactions | 1.83e-04 | 72 | 31 | 3 | int:UBFD1 | |
| Interaction | YAP1 interactions | 1.90e-04 | 1095 | 31 | 8 | int:YAP1 | |
| Interaction | SMAP2 interactions | 1.93e-04 | 189 | 31 | 4 | int:SMAP2 | |
| Interaction | DOK4 interactions | 1.98e-04 | 74 | 31 | 3 | int:DOK4 | |
| Interaction | KIF4B interactions | 2.06e-04 | 14 | 31 | 2 | int:KIF4B | |
| Interaction | H2BC8 interactions | 2.13e-04 | 576 | 31 | 6 | int:H2BC8 | |
| Interaction | FOXL1 interactions | 2.22e-04 | 196 | 31 | 4 | int:FOXL1 | |
| Interaction | FZD7 interactions | 2.23e-04 | 77 | 31 | 3 | int:FZD7 | |
| Interaction | POU5F1 interactions | 2.29e-04 | 584 | 31 | 6 | int:POU5F1 | |
| Interaction | GATA2 interactions | 2.36e-04 | 199 | 31 | 4 | int:GATA2 | |
| Interaction | SOX7 interactions | 2.69e-04 | 82 | 31 | 3 | int:SOX7 | |
| Interaction | GUCA2A interactions | 2.71e-04 | 16 | 31 | 2 | int:GUCA2A | |
| Interaction | FKBP2 interactions | 2.79e-04 | 83 | 31 | 3 | int:FKBP2 | |
| Interaction | ACBD5 interactions | 2.84e-04 | 209 | 31 | 4 | int:ACBD5 | |
| Interaction | SCG2 interactions | 3.07e-04 | 17 | 31 | 2 | int:SCG2 | |
| Interaction | COL9A2 interactions | 3.07e-04 | 17 | 31 | 2 | int:COL9A2 | |
| Interaction | GSC interactions | 3.20e-04 | 87 | 31 | 3 | int:GSC | |
| Interaction | NPY interactions | 3.45e-04 | 18 | 31 | 2 | int:NPY | |
| Interaction | DPRX interactions | 3.45e-04 | 18 | 31 | 2 | int:DPRX | |
| Interaction | PRAP1 interactions | 3.45e-04 | 18 | 31 | 2 | int:PRAP1 | |
| Interaction | NBL1 interactions | 3.45e-04 | 18 | 31 | 2 | int:NBL1 | |
| Interaction | DUXB interactions | 3.45e-04 | 18 | 31 | 2 | int:DUXB | |
| Interaction | CDIP1 interactions | 3.45e-04 | 18 | 31 | 2 | int:CDIP1 | |
| Interaction | H2BC3 interactions | 3.57e-04 | 406 | 31 | 5 | int:H2BC3 | |
| Interaction | SNRNP40 interactions | 3.65e-04 | 637 | 31 | 6 | int:SNRNP40 | |
| Interaction | SPAG8 interactions | 3.65e-04 | 91 | 31 | 3 | int:SPAG8 | |
| Interaction | PRMT2 interactions | 3.65e-04 | 91 | 31 | 3 | int:PRMT2 | |
| Interaction | RAD23A interactions | 3.69e-04 | 224 | 31 | 4 | int:RAD23A | |
| Interaction | CSN3 interactions | 3.85e-04 | 19 | 31 | 2 | int:CSN3 | |
| Interaction | FLNA interactions | 4.00e-04 | 648 | 31 | 6 | int:FLNA | |
| Interaction | IST1 interactions | 4.02e-04 | 94 | 31 | 3 | int:IST1 | |
| Interaction | MLLT6 interactions | 4.14e-04 | 95 | 31 | 3 | int:MLLT6 | |
| Interaction | RAI2 interactions | 4.28e-04 | 20 | 31 | 2 | int:RAI2 | |
| Cytoband | 12q12 | 4.68e-04 | 47 | 31 | 2 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 2.90e-03 | 118 | 31 | 2 | chr5q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 4.57e-03 | 149 | 31 | 2 | chr2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.02e-02 | 226 | 31 | 2 | chr2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 1.51e-02 | 278 | 31 | 2 | chr16p11 | |
| GeneFamily | Ubiquilin family | 1.80e-08 | 5 | 23 | 3 | 783 | |
| GeneFamily | Septins | 1.20e-04 | 13 | 23 | 2 | 732 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.61e-04 | 15 | 23 | 2 | 529 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.55e-03 | 46 | 23 | 2 | 622 | |
| Coexpression | KRAS.AMP.LUNG_UP.V1_DN | 2.32e-05 | 142 | 31 | 4 | M2859 | |
| Coexpression | GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP | 3.61e-05 | 159 | 31 | 4 | M8814 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 8.64e-05 | 199 | 31 | 4 | M7374 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP | 8.64e-05 | 199 | 31 | 4 | M8734 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 8.81e-05 | 200 | 31 | 4 | M6372 | |
| Coexpression | GSE3982_DC_VS_TH1_UP | 8.81e-05 | 200 | 31 | 4 | M5481 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 8.81e-05 | 200 | 31 | 4 | M9188 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.10e-04 | 212 | 31 | 4 | MM3816 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.37e-04 | 429 | 31 | 5 | M29 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.63e-06 | 815 | 31 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 2.69e-05 | 417 | 31 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 8.54e-05 | 161 | 31 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 1.29e-04 | 804 | 31 | 7 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 1.32e-04 | 68 | 31 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_500 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.05e-06 | 191 | 31 | 4 | 588015d76b68488da6aa6603777682f3d81592bf | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.63e-06 | 194 | 31 | 4 | ded64ddab86de17fcf8b70d31bc26796eb71d60f | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.09e-05 | 200 | 31 | 4 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 7.12e-05 | 116 | 31 | 3 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-04 | 148 | 31 | 3 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.81e-04 | 159 | 31 | 3 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 163 | 31 | 3 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-04 | 165 | 31 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 166 | 31 | 3 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 166 | 31 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 166 | 31 | 3 | 3695407e4638f3c18fbff63daba52baa9256c429 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 167 | 31 | 3 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-04 | 168 | 31 | 3 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 169 | 31 | 3 | 822e5b6c1e55e196e6d2a38bf183fd220c45703e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 169 | 31 | 3 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 171 | 31 | 3 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 171 | 31 | 3 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 174 | 31 | 3 | 2afa5eea54b67c549c5058ece98296eee3829c11 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 180 | 31 | 3 | 42f48e646fc6e72ad3cce72409ace3a0b64020a2 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 181 | 31 | 3 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 181 | 31 | 3 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 181 | 31 | 3 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 2.69e-04 | 182 | 31 | 3 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 2.82e-04 | 185 | 31 | 3 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-04 | 187 | 31 | 3 | 69068480f6819a6c8560ecbb05deb156b4055e12 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-04 | 187 | 31 | 3 | 9c8b932a15b8b50982cba4cf8db750e257eb9503 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-04 | 187 | 31 | 3 | 46e15419e80bd7180f3171a99d845b01bb635e53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-04 | 187 | 31 | 3 | 0d17b07770e4c881a7ca53a5bd42471457d198fb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-04 | 187 | 31 | 3 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.96e-04 | 188 | 31 | 3 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.96e-04 | 188 | 31 | 3 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 189 | 31 | 3 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 3.05e-04 | 190 | 31 | 3 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.05e-04 | 190 | 31 | 3 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 190 | 31 | 3 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.05e-04 | 190 | 31 | 3 | 69c5c4d5f4fb6e5ae2c9dbf9d209faf093c3f769 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 191 | 31 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 191 | 31 | 3 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.10e-04 | 191 | 31 | 3 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.10e-04 | 191 | 31 | 3 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.10e-04 | 191 | 31 | 3 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 191 | 31 | 3 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 194 | 31 | 3 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.34e-04 | 196 | 31 | 3 | 1b06639b7d2b81a1e5bcc455f3adda039f42ba57 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 196 | 31 | 3 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 196 | 31 | 3 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.40e-04 | 197 | 31 | 3 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-04 | 197 | 31 | 3 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-04 | 197 | 31 | 3 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 197 | 31 | 3 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 197 | 31 | 3 | 8e655db7c6f04d49927a1f0a75178e5955b4af08 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.45e-04 | 198 | 31 | 3 | 1fa213e79d828bff6465bde116536dd1b80d94e0 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for bronchial biopsy | 3.45e-04 | 198 | 31 | 3 | d5306121a75c5eb37d62c353799a98e6ba5ab63f | |
| ToppCell | Healthy_Control-Lymphoid|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.45e-04 | 198 | 31 | 3 | c176c583f426e4373daca4a696ab8832e838cfbf | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.45e-04 | 198 | 31 | 3 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_T_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.50e-04 | 199 | 31 | 3 | 1d55d06e658939b78ea046553757821381eaa026 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 3.50e-04 | 199 | 31 | 3 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.50e-04 | 199 | 31 | 3 | 53b3d35767889a152f1f38e8f6f0ba8f7a7690f2 | |
| ToppCell | Healthy_Control-Lymphoid-T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.50e-04 | 199 | 31 | 3 | f22438fc9c02d0a4d7c936f9420b913aca851ea1 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.50e-04 | 199 | 31 | 3 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 3.55e-04 | 200 | 31 | 3 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.55e-04 | 200 | 31 | 3 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 60d11275f06490f86f400a2802492f9c1b570400 | |
| ToppCell | Severe-Lymphoid-T-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 3.55e-04 | 200 | 31 | 3 | 266270c756fb69945449ce02da04743cd31f8158 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 4c22a1f35ff496fa6af2ab171f2936785272bc06 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | b71138729d2a81cc2f30e3bc15853516a525a17f | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.55e-04 | 200 | 31 | 3 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 02594c1edbc9f2cf831639cd83363abd2551cb94 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 3.55e-04 | 200 | 31 | 3 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(52)_cycling_DCs|Caecum / shred on region, Cell_type, and subtype | 3.55e-04 | 200 | 31 | 3 | 3b04d08e9122c23f42f66bc74c06cf24e1693987 | |
| ToppCell | Caecum-Dendritic_cell-cycling_DCs|Caecum / Region, Cell class and subclass | 3.55e-04 | 200 | 31 | 3 | 608be9bfe74f8d3202aa92b2905452a06f340f76 | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 3.55e-04 | 200 | 31 | 3 | c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.55e-04 | 200 | 31 | 3 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 3.55e-04 | 200 | 31 | 3 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_T_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.55e-04 | 200 | 31 | 3 | dd374e153106fff8a22483ba7f63b3fa3d3ab2ea | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-04 | 200 | 31 | 3 | 6145bdee0d9954da7b096be4fe797066a6df2bd0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 46521d83b917b0357601db8783c8da6b73730d60 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Stem_cells-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 8f3067b52865a0f5488e4df0d5a4fea80135cef5 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Stem_cells-Neuroepithelial_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 0632b8d3a1be437f146bc86aae9646303e37a0bd | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-04 | 200 | 31 | 3 | f95769e24763900eac317c6f8adbf064bae9feaf | |
| Drug | 2f34 | 5.19e-06 | 188 | 31 | 5 | CID006420160 | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.02e-06 | 200 | 31 | 5 | 4701_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 7.02e-06 | 200 | 31 | 5 | 5853_DN | |
| Drug | chloroacetyl-CoA | 1.07e-05 | 4 | 31 | 2 | CID003081467 | |
| Drug | androstan-3-ol | 2.68e-05 | 6 | 31 | 2 | ctd:C000658 | |
| Drug | retinyl stearate | 3.75e-05 | 7 | 31 | 2 | CID006438398 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.53e-05 | 161 | 31 | 4 | 4768_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.43e-05 | 177 | 31 | 4 | 6972_DN | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.17e-04 | 187 | 31 | 4 | 3037_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A | 1.37e-04 | 195 | 31 | 4 | 6339_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A | 1.37e-04 | 195 | 31 | 4 | 1292_UP | |
| Drug | arteether | 1.39e-04 | 13 | 31 | 2 | CID000072416 | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 5827_DN | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; HL60; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 3064_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 1326_UP | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 6890_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 7138_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 3126_DN | |
| Drug | Florfenicol [73231-34-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 5300_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.45e-04 | 198 | 31 | 4 | 1073_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 5871_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 4659_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 3142_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 3410_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 5781_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.51e-04 | 200 | 31 | 4 | 5782_DN | |
| Drug | K2PtCl4 | 1.62e-04 | 14 | 31 | 2 | CID003013632 | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 9.48e-10 | 3 | 30 | 3 | DOID:0060206 (implicated_via_orthology) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 2.07e-07 | 12 | 30 | 3 | DOID:9255 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 3.78e-06 | 30 | 30 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | phosphatidylcholine measurement | 1.89e-04 | 284 | 30 | 4 | EFO_0010226 | |
| Disease | testosterone measurement | 2.35e-04 | 1275 | 30 | 7 | EFO_0004908 | |
| Disease | Immunologic Deficiency Syndromes | 2.49e-04 | 23 | 30 | 2 | C0021051 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 2.72e-04 | 24 | 30 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.28e-04 | 145 | 30 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 6.02e-04 | 163 | 30 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma | 7.28e-04 | 174 | 30 | 3 | EFO_0000571 | |
| Disease | obesity (implicated_via_orthology) | 1.34e-03 | 215 | 30 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | neutrophil count, basophil count | 1.51e-03 | 224 | 30 | 3 | EFO_0004833, EFO_0005090 | |
| Disease | breast carcinoma (is_marker_for) | 2.06e-03 | 66 | 30 | 2 | DOID:3459 (is_marker_for) | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 2.25e-03 | 69 | 30 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | Prostatic Neoplasms | 3.35e-03 | 616 | 30 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.35e-03 | 616 | 30 | 4 | C0376358 | |
| Disease | reaction time measurement | 4.24e-03 | 658 | 30 | 4 | EFO_0008393 | |
| Disease | glycoprotein measurement | 6.52e-03 | 119 | 30 | 2 | EFO_0004555 | |
| Disease | C-reactive protein measurement | 6.88e-03 | 1206 | 30 | 5 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EQQKMHLMDQPNRMM | 76 | Q9P2D1 | |
| MIQQQNMQQPMNVMT | 506 | Q14677 | |
| MTIRQQIMQLKIMTN | 451 | P35052 | |
| AMKQAVMEMMSQKIQ | 126 | Q99471 | |
| QLIMQSEMRERQMAM | 31 | Q9HBL7 | |
| MRMISRMSQNVDMPK | 621 | Q5TB30 | |
| QQQQQQQMMMMLMMQ | 1026 | Q14686 | |
| EMMQTAMQNTMLING | 281 | P01031 | |
| NMNMNVNMNMNMNLN | 771 | Q86UU0 | |
| VNMNMNMNLNVQMTP | 776 | Q86UU0 | |
| VQMTPQQQMLMSQKM | 786 | Q86UU0 | |
| QRKIMLNMFLDTMMA | 201 | O60941 | |
| RMMKNQRVQLMRQMK | 641 | O95239 | |
| WMMKNQRVQLMRQMK | 641 | Q2VIQ3 | |
| QQEISSMQMKLMEMK | 486 | P42566 | |
| TLMMEQRSQMLKQMQ | 926 | Q9Y666 | |
| NMMQPQMNVMQQQMN | 1206 | Q99590 | |
| MSAQAQMRAMLDQLM | 1 | Q9Y383 | |
| QISMRQEMELAMKML | 366 | Q7L099 | |
| MCNVMMQLRKMANHP | 771 | Q9H4L7 | |
| TNVQNMNPMMAQMQM | 1326 | Q15788 | |
| RMMVENIMNKEAFMN | 446 | O94844 | |
| MPMSFQMQTQMLTRL | 676 | O15047 | |
| RRMQEMLEKMQAQMQ | 346 | Q8WYJ6 | |
| DMIMQHKRAMQDMQL | 456 | Q8IWZ8 | |
| HMHNMMLLQQNMKQI | 791 | Q86UP3 | |
| AMMQEMMRNQDRALS | 246 | Q9UMX0 | |
| NKMTVMNVAMVMAPN | 471 | Q8N392 | |
| VRQNRSKENVSMMML | 726 | Q8N9V7 | |
| RMQEMIARMQAQMQM | 331 | Q15019 | |
| MQQQLMASPEMMIQI | 171 | Q9UHD9 | |
| RHMIMANPQMQQLME | 216 | Q9NRR5 | |
| AMMQEMMRNQDRALS | 256 | Q9NRR5 | |
| EKHMHNMMLLQQNMT | 826 | Q15911 |